Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival
Alessandra De Remigis, Tanja D. De Gruijl, Jennifer N. Uram, Shey-Cherng Tzou, Shintaro Iwama, Monica V. Talor, Todd D. Armstrong, Saskia J.A.M. Santegoets, Susan F. Slovin, Lei Zheng, Daniel A. Laheru, Elizabeth M. Jaffee, Winald R. Gerritsen, Alfons J.M. Van Den Eertwegh, Dung T. Le, Patrizio Caturegli*